Latest common stock for DMAQU: $160.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
As of the most recent data (June 2026), DMAQU shows a common stock of $160. That compares with $100 in the prior-year period — up 60.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, DMAQU's common stock is now $160 (was $100) — a 60.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) is outperforming or lagging.
Tracking DMAQU's common stock over time shows whether Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) is scaling, shrinking, or reshaping that part of the business. The current reading is $160 That compares with $100 in the prior-year period — up 60.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this common stock page, Stockcircle has Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $160) with ownership activity and broader fundamentals.